GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » 3-Year FCF Growth Rate

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) 3-Year FCF Growth Rate : 103.30% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi 3-Year FCF Growth Rate?

Laboratorios Farmaceuticos Rovi's Free Cash Flow per Share for the three months ended in Dec. 2023 was €0.63.

During the past 12 months, Laboratorios Farmaceuticos Rovi's average Free Cash Flow per Share Growth Rate was -68.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 103.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Laboratorios Farmaceuticos Rovi was 103.30% per year. The lowest was -31.00% per year. And the median was 23.45% per year.


Competitive Comparison of Laboratorios Farmaceuticos Rovi's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Laboratorios Farmaceuticos Rovi's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorios Farmaceuticos Rovi's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's 3-Year FCF Growth Rate falls into.



Laboratorios Farmaceuticos Rovi 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Laboratorios Farmaceuticos Rovi  (XMAD:ROVI) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Laboratorios Farmaceuticos Rovi 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Traded in Other Exchanges
Address
Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.